Authors
Latest:
Ronald Crystal, MD: The Possibilities of Gene Therapy in Neurodegenerative DiseaseThe chairman of the Department of Genetic Medicine at Weill Cornell Medicine detailed the ongoing research in developing gene therapy for patients with Alzheimer disease.
Latest:
Anna Heidbreder, MD: Anti-IgLON5 Disease, REM Sleep Behavior DisorderHeidbreder further described the current understanding of the condition and what she and her colleagues have found out.
Latest:
Ricardo Osorio, MD: Unanswered Questions About the Relationship Between Sleep, Alzheimer DiseaseThe associate professor at NYU Langone discussed several of the questions that remained unanswered about the relationship between sleep and Alzheimer disease.
Latest:
Neurologic Complications of COVID-19 ReportedThe first presumptive case of acute necrotizing encephalopathy in a patient with confirmed COVID-19 has been published in the journal Radiology.
Latest:
Sanjeev V. Thomas, MD, DM: Managing Epilepsy During PregnancyThe chief of neurology at Sree Chitra Tirunal Institute for Medical Sciences and Technology spoke about how to reassure patients with epilepsy who are planning for pregnancy and how to make treatment decisions with pregnant patients.
Latest:
Bruce Trapp, PhD: Insights Gleaned from Myelocortical Multiple SclerosisThe chairman of the Department of Neuroscience at the Lerner Research Institute spoke about what the implications of the new subtype of MS could be in the understanding of the disease.
Latest:
Rick Wassing, MSc, PhD-C: Restless REM Sleep Contributes to Hyperarousal In InsomniaThose suffering from significant emotional distress and sleep disturbances may benefit from targeted interventions to restore consolidated REM sleep or prevent the occurrence of fragmented REM sleep.
Latest:
World Alzheimer Day 2019: Key Takeaways From Leaders in Alzheimer Disease and DementiaIn recognition of World Alzheimer Day, experts in Alzheimer disease and dementia share insight from the latest Alzheimer Disease International's yearly World Alzheimer Report.
Latest:
ENSEMBLE Study Results, Ocrelizumab as Promising Early Treatment for MS: Robert A. Bermel, MDThe director of the Mellen Center for MS at Cleveland Clinic talked about the ENSEMBLE study results that were presented at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]
Latest:
Lisa Eunyoung Lee, MS, BSc: Myelin Water Imaging in the Spinal CordThe research assistant at the University of British Columbia-Vancouver detailed the success of myelin water imaging in the spinal cords of both healthy controls and patients with multiple sclerosis.
Latest:
Efficacy of Fenfluramine in Reducing Generalized Tonic-Clonic Seizures: Kelly Knupp, MDThe pediatric epileptologist at Children's Hospital Colorado talked about a comprehensive review of various studies assessing fenfluramine in severe seizures associated with developmental and epileptic encephalopathies. [WATCH TIME: 5 minutes]
Latest:
COMT Inhibitors Assist in Control of Parkinson Disease Motor SymptomsMore recently, investigators have discovered that catechol-O-methyltransferase inhibitors can prolong the effects of levodopa, thereby limiting the off-time phenomenon.
Latest:
Lynn Liu, MD: When Should We Measure Antiepileptic Blood Levels?The associate professor of neurology at the University of Rochester shared some of her advice for treating patients with epilepsy and focusing on the patient.
Latest:
California Startup Exploring Novel ALS Discovery PlatformA grant from the National Institute of Neurological Disorders and Stroke, which allows for concurrent phase I and II trial design review, will speed up the development of novel treatments for patients with ALS and FTD.
Latest:
David Kemlink, MD, PhD: Actigraphic Recordings in Rapid Eye Movement Sleep Behavior DisorderActigraphic recording from upper extremities show consistently more prominent sleep fragmentation in rapid eye movement sleep behavior disorder patients compared to other sleep diagnoses.
Latest:
Page B. Pennell, MD: Improving Epilepsy Care in 2020 and BeyondThe president of the American Epilepsy Society and director of epilepsy research at Brigham and Women’s Hospital outlined the state of epilepsy care and what we can expect in 2020.
Latest:
Paul Durham, PhD: A Combination Approach With nVNS in MigraineThe distinguished professor and director of cell biology at Missouri State University discussed the use of nVNS in migraine treatment and whether or not it can replace the use of or be used in conjunction with triptans—a medication on which many patients fail or report poor response on.
Latest:
Video: Multisymptomatic Care in Parkinson's DiseaseStuart Isaacson, MD, Rajesh Pahwa, MD, and Jennifer Goldman, MD discuss optimizing PD treatment with levodopa and adjunct therapies, addressing patient and pharmacologic challenges, coordinating care, and anticipating the impact of emerging therapies and upcoming Medicare Part D changes.
Latest:
EEG Abnormalities in Acutely Ill Patients With COVID-19Preliminary findings from a retrospective sample series in the Bronx, New York.
Latest:
The Treatment of Status Migrainosus in Emergency Care Settings: Matthew Robbins, MDThe neurologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital offered his insight into the state of treatment for status migrainosus and whether or not the new migraine medications can help improve care. [WATCH TIME: 2 minutes]
Latest:
Bryan Davis, PsyD, MS: Future Discussion on Masculinity Norms in MSThe clinical health psychology fellow at Cleveland Clinic’s Mellen Center for MS Treatment and Research at Cleveland Clinic details the interventions for men with MS and how the study can change the discussion on masculinity norms.
Latest:
Awareness Empowers Care for Patients With Parkinson DiseaseParkinson disease is neither imminently fatal nor transient but is incurable, and as it affects individuals differently based on their unique identities, culture, access to health care, and social support, it is vital to empower patients.
Latest:
EEG Abnormalities in Acutely Ill Patients With COVID-19Preliminary findings from a retrospective sample series in the Bronx, New York.
Latest:
Question and Answer about Neurofilament Light Chain and Other MS BiomarkersMark Freedman, MD, MSc, Tanuja Chitnis, MD, and Ahmed Obeidat, MD, PhD, answer questions about biomarkers in MS care.
Latest:
Unmet Needs in the Treatment of Spinal Muscular AtrophyA panel of experts considers current unmet needs in SMA by emphasizing the need for further study of combination therapy, more comprehensive newborn screening, and more effective early diagnosis and treatment.
Latest:
Alexander Kolevzon, MD: The STARS Study in Angelman SyndromeThe director of Child and Adolescent Psychiatry at Mount Sinai Health System spoke about the results of the phase 2 study of OV101 (gaboxadol), and the next steps for the phase 3 trial.
Latest:
Unraveling the Complexity of Fatigue in Multiple Sclerosis: John DeLuca, PhDThe senior vice president for Research and Training at Kessler Foundation talked about the issue of fatigue in patients with multiple sclerosis and the significant, multifaceted challenges patients face. [WATCH TIME: 5 minutes]
Latest:
Hillary Thomas, PhD: Screening Patients With Epilepsy for DepressionThe pediatric psychologist at Children’s Medical Center discussed what her team does to assess patients in the clinic when something comes up as a result of a patient’s screening.
